PREVENT Cancer Preclinical Drug Development Program (PREVENT) supports the best ideas in cancer prevention using NCI contract resources

The 88 projects in PREVENT involve:

54 Chemoprevention
26 Immunoprevention
8 Biomarkers

Preclinical Drug Development Piplines involves:

Proof of Concept
- 22 Chemoprevention
- 19 Immunoprevention
- 8 Biomarkers
Secondary Testing
- 23 Chemoprevention
- 3 Immunoprevention
Advances Pre-Clinical Development
- 9 Chemoprevention
- 4 Immunoprevention

Reusable Info

Information for Reuse

Infographics in this collection offer quick and clear visual representations of some of the more complex aspects of cancer, scientific study, and the National Cancer Institute (NCI) as the federal government’s lead agency for cancer research. These multimedia assets are in the public domain, may be used free of charge for any educational or non-commercial purpose, and cannot be copyrighted. They may not be used to state or imply NCI’s endorsement of any commercial product, service, or activity. Please credit the source of these products as: The National Cancer Institute.

Division of Cancer Prevention